ZEOX Zeo ScientifiX, Inc.

OTC Biological Products, (No Diagnostic Substances) NV CIK: 0001557376
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

Zeo ScientifiX faces a critical solvency crisis with negative stockholders' equity of -$383K and a severe liquidity crisis (current ratio 0.70x), indicating liabilities exceed assets. With operating cash burn of -$471K annually against only $1.0M in cash reserves, the company has approximately 2 years of runway while failing to achieve profitability on $1.4M revenue. While the 80.6% gross margin demonstrates strong unit economics, operating losses of -$878K reveal unsustainable overhead that must be cut dramatically or revenue must scale 5-10x for viability.

Strengths

  • + Revenue growth of 12.5% YoY demonstrates market traction
  • + Gross margin of 80.6% indicates healthy unit economics and strong product pricing power
  • + $1.0M cash on hand provides short-term liquidity cushion

Risks

  • ! Negative stockholders' equity of -$383K indicates technical insolvency and accounting distress
  • ! Current ratio of 0.70x and quick ratio of 0.52x signal inability to meet near-term obligations
  • ! Operating cash burn of -$471K annually is unsustainable with ~$1M cash (2-year runway at current burn)
  • ! Operating margin of -60.7% with $878K operating loss indicates overhead costs are 63x revenue
  • ! No insider buying activity in past 90 days suggests management lacks confidence

Key Metrics to Watch

Financial Metrics

Revenue
1.4M
Net Income
-852.0K
EPS (Diluted)
$-0.12
Free Cash Flow
-485.0K
Total Assets
2.6M
Cash
1.0M

Profitability Ratios

Gross Margin 80.6%
Operating Margin -60.7%
Net Margin -58.9%
ROE N/A
ROA -33.1%
FCF Margin -33.5%

Balance Sheet & Liquidity

Current Ratio
0.70x
Quick Ratio
0.52x
Debt/Equity
N/A
Debt/Assets
114.9%
Interest Coverage
-87.80x
Long-term Debt
51.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-19T21:30:26.113708 | Data as of: 2026-01-31 | Powered by Claude AI